192Dose-reduced conditioning with fludarabine/melphalan followed by allogeneic stem cell transplantation for patients with advanced stage II/III multiple myeloma

Authors :: G. Wittkowsky
F Ayuk
Michael G. Kiehl
Avichai Shimoni
Arnon Nagler
N Kröger
Tatjana Zabelina
Herbert G. Sayer
Axel R. Zander
Rainer Schwerdtfeger
Helmut Renges
Hannes Wandt
Source :: Biology of Blood and Marrow Transplantation. 9:121
Publication Year :: 2003
Publisher :: Elsevier BV, 2003.

Subjects :: Oncology
Transplantation
medicine.medical_specialty
business.industry
Advanced stage
Fludarabine/Melphalan
Hematology
medicine.disease
Internal medicine
medicine
Stem cell
business
Multiple myeloma

Full Text Access

Tools